BioCardia BCDA
NASDAQ BCDA
$1.01 -0.02 (-1.94%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioCardia (BCDA) Cash from Financing Activities (2010 - 2026)

Updated

BioCardia's Cash from Financing Activities came in at $4.9 million for Q2 2026, up 191.6% from $1.68 million a year earlier.

Analysis

BioCardia (BCDA) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioCardia reported Cash from Financing Activities of $10.71 million, up 36.0% year-over-year; for FY2025, it came in at $7.57 million, down 17.4% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of -23.1% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $9.16 million in FY2024 (+145.8%), $3.73 million in FY2023 (-27.3%), $5.12 million in FY2022 (+163.1%) and $1.95 million in FY2021 (-93.1%).
  • The five-year range for quarterly Cash from Financing Activities is -$288,000 (Q4 2025) to $6.12 million (Q3 2024).
  • Year-over-year, Cash from Financing Activities increased in 1 of the last five quarters, with growth averaging 11.4%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q3 2022 (growth of 812.5%), and the weakest in Q1 2025 (a decline of 85.8%).
  • Business Quant data shows BCDA's Cash from Financing Activities at $117,000 (Q1 2026), -$288,000 (Q4 2025) and $5.98 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 BioCardia 12.21 Mn -649,799.44 - 4.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.90 Mn
Mar 31, 2026 117,000.00
Dec 31, 2025 -288,000.00
Sep 30, 2025 5.98 Mn
Jun 30, 2025 1.68 Mn
Mar 31, 2025 196,000.00
Dec 31, 2024 -125,000.00
Sep 30, 2024 6.12 Mn
Jun 30, 2024 1.79 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 1.12 Mn
Sep 30, 2023 -58,000.00
Jun 30, 2023 2.60 Mn
Mar 31, 2023 64,000.00
Dec 31, 2022 3.70 Mn
Sep 30, 2022 73,000.00
Jun 30, 2022 1.35 Mn
Sep 30, 2021 8,000.00
Jun 30, 2021 -66,000.00
Mar 31, 2021 2.01 Mn
API Access

BioCardia Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BCDA&period=max&api_key=YOUR_API_KEY